arbiter
JournalsPricingAccount

Cost consequence minimization and budget impact model for introducing the fully liquid combined acellular hexavalent vaccine into the Dominican Republic’s expanded immunization plan

Rosa Acevedo Saladin et al.

Expert Review of Pharmacoeconomics & Outcomes Research2026https://doi.org/10.1080/14737167.2025.2610735article
ABDC C
Weight
0.50

What the paper says

The incorporation of the hexavalent vaccine increases spending but reduces adverse events, logistics cost, and productivity losses, supporting modernization of the DR immunization program.

Open paper page →

Cite this paper

https://doi.org/https://doi.org/10.1080/14737167.2025.2610735

Or copy a formatted citation

@article{rosa2026,
  title        = {{Cost consequence minimization and budget impact model for introducing the fully liquid combined acellular hexavalent vaccine into the Dominican Republic’s expanded immunization plan}},
  author       = {Rosa Acevedo Saladin et al.},
  journal      = {Expert Review of Pharmacoeconomics & Outcomes Research},
  year         = {2026},
  doi          = {https://doi.org/https://doi.org/10.1080/14737167.2025.2610735},
}

Paste directly into BibTeX, Zotero, or your reference manager.

Flag this paper

Cost consequence minimization and budget impact model for introducing the fully liquid combined acellular hexavalent vaccine into the Dominican Republic’s expanded immunization plan

Flags are reviewed by the Arbiter methodology team within 5 business days.

Evidence weight

0.50

Balanced mode · F 0.40 / M 0.15 / V 0.05 / R 0.40

F · citation impact0.50 × 0.4 = 0.20
M · momentum0.50 × 0.15 = 0.07
V · venue signal0.50 × 0.05 = 0.03
R · text relevance †0.50 × 0.4 = 0.20

† Text relevance is estimated at 0.50 on the detail page — for your query’s actual relevance score, open this paper from a search result.